Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)

Bug, G, Burchert, A, Wagner, E-M, Kröger, N, Berg, T, Güller, S, Metzelder, S K, Wolf, A, Hünecke, S, Bader, P, Schetelig, J, Serve, H and Ottmann, Oliver ORCID: https://orcid.org/0000-0001-9559-1330 2017. Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial). Leukemia 31 (11) , pp. 2523-2525. 10.1038/leu.2017.242

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (144kB) | Preview

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine
Additional Information:	This work is licensed under a Creative Commons Attribution 4.0 International License
Publisher:	Nature Publishing Group
ISSN:	0887-6924
Date of First Compliant Deposit:	2 February 2018
Date of Acceptance:	28 July 2017
Last Modified:	05 May 2023 18:29
URI:	https://orca.cardiff.ac.uk/id/eprint/108724

Citation Data

Cited 57 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item